Xip Diagnostics develops analytical solutions that advance human and animal health at the point of need through in-house product development and industry-leading collaborations.
The company's disposable blood analyzers wirelessly upload lab-quality clinical measurements in minutes, providing blood testing with no hassles, no delays, and no instrument. These devices will be deployed in Emergency Departments (EDs), clinics, and eventually the home.
Xip Diagnostics Founder and CEO Dr. Octavian Florescu spun out the company to commercialize research discoveries made while he was a PhD student in the lab of UC Berkeley Professor of Electrical Engineering Bernhard Boser.
Formerly known as Silicon BioDevices LLC. The company was acquired by In Diagnostics in 2021.
Timeline
2009. Company founded.
2018. Changed name to Xip Diagnostics.
2021. Acquired by In Diagnostics.
Company Details
- Founded
- -
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.indiagnostics.com/
- Competitors
- In Diagnostics, Umicore.
Xip Diagnostics Questions
Xip Diagnostics's website is https://www.indiagnostics.com/
Xip Diagnostics's LinkedIn profile is https://www.linkedin.com/company/xip-diagnostics2
Xip Diagnostics's industry is
Biotechnology Research
Xip Diagnostics's top competitors are
In Diagnostics,
Umicore.
Xip Diagnostics's categories are Biotechnology Research
Xip Diagnostics's founding year is 2009
